CN Stock MarketDetailed Quotes

600518 Kangmei Pharmaceutical

Watchlist
  • 1.72
  • -0.01-0.58%
Market Closed Sep 13 15:00 CST
23.85BMarket Cap95.56P/E (TTM)

Kangmei Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Assets
Current assets
Money funds
-37.81%794.97M
-42.33%744.68M
-29.91%1.06B
-40.41%1.19B
-37.62%1.28B
-40.98%1.29B
-37.67%1.51B
214.63%1.99B
190.35%2.05B
276.72%2.19B
Transactional financial assets
-27.14%72.76K
-33.90%77.54K
-29.42%82.8K
--91.46K
--99.86K
-93.33%117.31K
-77.63%117.31K
----
----
--1.76M
Notes receivable and accounts receivable
22.81%2.23B
11.48%2.2B
3.16%2.08B
19.64%1.89B
16.81%1.82B
23.29%1.97B
43.55%2.01B
-26.11%1.58B
-31.08%1.56B
-32.48%1.6B
-Notes receivable
106.61%60.21M
-1.49%54.95M
-1.00%49.46M
-9.83%53.02M
-38.19%29.14M
15.58%55.78M
6.52%49.96M
-15.98%58.8M
12.36%47.15M
204.41%48.26M
-Accounts receivable
21.45%2.17B
11.86%2.14B
3.27%2.03B
20.78%1.84B
18.52%1.79B
23.53%1.92B
44.83%1.96B
-26.45%1.52B
-31.90%1.51B
-34.07%1.55B
Other receivables (including interest and dividends)
-10.58%722.91M
-7.87%738.35M
-10.41%709.24M
-5.41%772.13M
-15.43%808.44M
-15.52%801.41M
-15.10%791.68M
-90.93%816.25M
-89.36%955.98M
-89.48%948.62M
-Other receivable
-10.58%722.91M
----
-10.41%709.24M
----
-15.43%808.44M
----
-15.10%791.68M
----
-89.36%955.98M
----
Advance payment
-6.45%131.17M
-11.94%156.87M
-32.48%117.93M
-8.37%146.59M
-15.17%140.22M
-5.25%178.15M
22.86%174.66M
-38.00%159.99M
-32.65%165.3M
-24.33%188.03M
Inventories
6.44%2.89B
5.96%2.81B
-3.89%2.64B
-15.18%2.81B
-14.33%2.71B
-15.74%2.65B
-13.90%2.75B
-41.12%3.32B
-43.28%3.17B
-44.24%3.14B
Receivable financing
19.06%26.82M
-72.65%12.29M
-32.71%16.3M
191.18%6.09M
1,832.20%22.52M
957.21%44.94M
-34.23%24.22M
-97.40%2.09M
-97.73%1.17M
-86.70%4.25M
Other current assets
3.77%196.68M
6.25%197.59M
55.64%187.25M
39.64%200.94M
38.47%189.54M
16.73%185.96M
-22.71%120.31M
-72.26%143.89M
-74.46%136.89M
-69.15%159.31M
Total current assets
0.34%6.99B
-3.76%6.86B
-7.78%6.81B
-12.40%7.02B
-13.21%6.97B
-13.48%7.12B
-10.87%7.38B
-56.13%8.01B
-56.27%8.03B
-55.27%8.23B
Non Current assets
Other equity investment
-19.73%1.12M
-18.67%1.13M
-17.19%1.15M
37.33%1.37M
39.75%1.4M
39.12%1.39M
39.12%1.39M
0.00%1M
0.00%1M
0.00%1M
Investment real estate
1.15%2.76B
1.29%2.78B
1.40%2.81B
23.36%2.7B
23.46%2.73B
23.61%2.75B
23.42%2.77B
-33.57%2.19B
-33.44%2.21B
-33.61%2.22B
Fixed assets
-7.24%3.37B
----
-7.64%3.45B
----
-11.07%3.63B
----
-10.96%3.73B
----
-19.68%4.09B
----
Constru in process
-17.79%172.64M
----
-2.29%210.56M
----
-20.68%210.01M
----
-18.26%215.5M
----
-92.00%264.75M
----
Productive biological assets
-11.08%679.62K
-10.78%700.79K
-10.50%721.96K
-16.63%743.13K
-14.25%764.3K
-11.88%785.47K
-9.50%806.63K
--891.31K
--891.31K
--891.31K
Intangible assets
-8.39%469.98M
-8.50%474.16M
-7.32%491.02M
-9.92%507.82M
-9.82%513M
-9.75%518.21M
-8.61%529.79M
-45.40%563.73M
-45.46%568.83M
-55.70%574.2M
Development expenditure
----
----
----
----
----
----
----
----
--268.24K
-82.83%219.7K
Goodwill
0.00%106.35M
0.00%106.35M
0.00%106.35M
0.00%106.35M
0.00%106.35M
0.00%106.35M
0.00%106.35M
188.14%106.35M
188.14%106.35M
188.14%106.35M
Long deferred expense
-21.28%61.48M
-20.79%64.44M
-23.34%66.47M
-20.17%72.47M
-19.48%78.09M
-21.34%81.35M
-21.34%86.71M
-0.58%90.77M
-0.70%96.99M
0.57%103.43M
Deferred tax assets
1.84%100.4M
6.75%102.37M
4.66%101.48M
59.09%98.92M
59.63%98.59M
56.21%95.9M
59.78%96.97M
-72.76%62.18M
-72.62%61.77M
-75.44%61.39M
Usufruct assets
-15.51%193.57M
-4.34%211.46M
-6.51%217.54M
6.81%223.53M
4.21%229.09M
14.55%221.06M
24.62%232.69M
23.25%209.29M
44.04%219.84M
16.89%192.97M
Other non current assets
48.38%28.38M
62.58%23.43M
49.44%21.9M
-9.97%23.06M
-24.19%19.13M
-44.34%14.41M
-44.38%14.65M
-69.16%25.62M
-71.54%25.23M
-69.57%25.89M
Total non current assets
-4.64%7.26B
-4.27%7.35B
-4.03%7.47B
-0.05%7.55B
-0.31%7.62B
-0.12%7.68B
0.19%7.78B
-42.94%7.55B
-42.81%7.64B
-46.56%7.69B
Total assets
-2.26%14.26B
-4.02%14.21B
-5.86%14.28B
-6.41%14.56B
-6.92%14.59B
-7.03%14.8B
-5.52%15.17B
-50.59%15.56B
-50.60%15.67B
-51.45%15.92B
Liabilities
Current liabilities
Short term loan
99.81%23.41M
15.18%29.96M
2.02%26.14M
24.95%33.05M
-36.04%11.72M
45.24%26.01M
68.84%25.62M
-98.22%26.45M
-98.77%18.32M
-99.23%17.91M
Notes payable and accounts payable
19.30%2.52B
6.93%2.41B
-11.98%2.26B
7.73%2.22B
7.55%2.12B
11.38%2.25B
27.22%2.56B
-31.35%2.06B
-36.31%1.97B
-36.24%2.02B
-Notes payable
145.31%89.96M
155.06%89.89M
68.85%51.33M
--48.83M
--36.67M
--35.24M
--30.4M
----
----
----
-Accounts payable
17.08%2.43B
4.58%2.32B
-12.95%2.21B
5.36%2.17B
5.69%2.08B
9.63%2.22B
25.71%2.53B
-31.35%2.06B
-36.31%1.97B
-36.24%2.02B
Contract liabilities
-23.61%151.91M
-26.51%143.82M
1.12%159.89M
-14.74%195.23M
1.12%198.86M
2.62%195.72M
-18.43%158.12M
-46.02%228.98M
-57.88%196.66M
-56.57%190.71M
Advance receipts
-31.21%45.29M
-35.94%40.55M
4.21%58.65M
-7.65%66.47M
-7.64%65.85M
-21.56%63.31M
-15.52%56.28M
27.98%71.98M
34.64%71.29M
12.96%80.7M
Salaries payable
-65.32%59.35M
-61.04%67.83M
-57.80%76.48M
-11.83%164.91M
-10.39%171.16M
-9.49%174.08M
-8.34%181.21M
-16.35%187.03M
-13.15%191M
-10.03%192.33M
Taxs payable
-57.89%405.33M
-58.69%406.88M
-42.79%571.3M
12.72%963.71M
9.79%962.66M
-2.50%984.88M
-1.78%998.55M
89.98%854.93M
94.56%876.83M
112.32%1.01B
Other payable (including interest and dividends)
0.29%1.37B
5.36%1.41B
5.54%1.4B
12.38%1.38B
11.18%1.37B
10.66%1.34B
7.51%1.33B
-70.28%1.23B
-70.30%1.23B
-70.60%1.21B
-Other payable
0.29%1.37B
----
5.54%1.4B
----
11.18%1.37B
----
7.51%1.33B
----
-48.02%1.23B
----
Non current liabilities due within one year
-9.34%36.28M
3.41%39.4M
4.08%40.71M
39.57%40.9M
29.98%40.02M
19.89%38.1M
6.03%39.12M
-99.80%29.3M
-99.79%30.79M
-99.66%31.78M
Other current liabilities
-5.31%84.76M
-2.25%83.4M
-2.77%85.88M
-88.32%89.3M
-44.52%89.51M
-47.82%85.32M
-47.03%88.32M
-73.81%764.37M
-94.47%161.35M
-94.39%163.5M
Total current liabilities
-6.39%4.7B
-10.23%4.63B
-13.99%4.68B
-5.48%5.15B
5.90%5.02B
4.87%5.16B
10.01%5.44B
-79.92%5.45B
-82.61%4.74B
-78.77%4.92B
Current liabilities
Long term account payable
-4.27%805.12M
----
-5.64%805.83M
----
195.44%841.01M
----
191.43%853.96M
----
--284.66M
----
Estimate liabilities
-15.14%823.83M
-15.04%832.44M
-12.76%855.54M
--894.27M
--970.78M
--979.81M
--980.63M
----
----
----
Deferred tax liabilities
-18.62%46.43M
-7.88%50.66M
-6.93%51.68M
--55.69M
--57.06M
--54.99M
--55.53M
----
----
----
Long term deferred income
-5.34%603.42M
-5.43%610.9M
-5.40%618.68M
-5.66%629.6M
-5.57%637.46M
-5.50%645.98M
-5.63%653.98M
-32.20%667.34M
-31.98%675.06M
-33.37%683.56M
Lease liabilities
-11.63%176.46M
-1.59%186.62M
-5.51%188.16M
3.64%195.86M
1.77%199.68M
12.78%189.63M
29.96%199.13M
11.91%188.98M
27.94%196.2M
1.27%168.15M
Total non current liabilities
-9.27%2.46B
-8.36%2.49B
-8.14%2.52B
148.30%2.58B
134.10%2.71B
137.01%2.71B
140.80%2.74B
-93.41%1.04B
-92.67%1.16B
-94.45%1.14B
Total liabilities
-7.40%7.16B
-9.59%7.12B
-12.03%7.2B
19.16%7.73B
31.01%7.73B
29.82%7.87B
34.49%8.18B
-84.88%6.49B
-86.29%5.9B
-86.15%6.06B
Shareholders equity
Paid-in capital
0.00%13.86B
0.00%13.86B
0.00%13.86B
0.00%13.86B
0.00%13.86B
0.00%13.86B
0.00%13.86B
178.73%13.86B
178.73%13.86B
178.73%13.86B
Capital reserve funds
0.00%18.78B
0.00%18.78B
0.00%18.78B
0.00%18.78B
0.00%18.78B
0.00%18.78B
0.00%18.78B
62.26%18.78B
62.26%18.78B
62.26%18.78B
Surplus reserve funds
0.00%1.53B
0.00%1.53B
0.00%1.53B
0.00%1.53B
0.00%1.53B
0.00%1.53B
0.00%1.53B
0.00%1.53B
0.00%1.53B
0.00%1.53B
Retained profit
0.93%-25.89B
0.62%-25.89B
0.39%-25.9B
-8.06%-26.15B
-11.13%-26.13B
-11.21%-26.05B
-11.53%-26B
24.93%-24.2B
26.85%-23.51B
26.35%-23.43B
Less:Treasury stock
0.45%1.22B
0.24%1.23B
0.26%1.23B
29.81%1.22B
30.67%1.22B
31.01%1.22B
30.99%1.22B
173.85%940.95M
171.48%932.82M
171.48%932.82M
Other composite income
-274.61%-251.97K
-190.09%-121.82K
-173.69%-100.05K
146.61%122.37K
154.89%144.31K
150.94%135.23K
151.15%135.77K
92.67%-262.52K
92.65%-262.93K
92.62%-265.45K
Specific reserves
16.33%1.37M
-6.80%1.21M
-1.35%1.28M
-65.76%1.15M
-65.02%1.18M
-61.51%1.3M
-61.51%1.3M
--3.36M
--3.37M
--3.37M
Shareholders equity without minority interests
3.49%7.06B
2.28%7.05B
1.43%7.05B
-24.71%6.8B
-29.86%6.83B
-29.72%6.9B
-30.00%6.95B
178.26%9.03B
185.01%9.73B
188.33%9.82B
Minority interests
9.58%35.75M
5.72%34.33M
-7.16%32.89M
-20.30%33.3M
-22.42%32.63M
-22.27%32.48M
-15.48%35.43M
-68.94%41.79M
-68.60%42.05M
-66.56%41.78M
Total shareholder equity
3.52%7.1B
2.29%7.09B
1.38%7.08B
-24.69%6.83B
-29.83%6.86B
-29.69%6.93B
-29.94%6.98B
179.55%9.07B
186.39%9.77B
189.71%9.86B
Total liabilityies and equity
-2.26%14.26B
-4.02%14.21B
-5.86%14.28B
-6.41%14.56B
-6.92%14.59B
-7.03%14.8B
-5.52%15.17B
-50.59%15.56B
-50.60%15.67B
-51.45%15.92B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Tianzhu International Accounting Firm (Special General Partnership)
--
--
--
Tianzhu International Accounting Firm (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Assets
Current assets
Money funds -37.81%794.97M-42.33%744.68M-29.91%1.06B-40.41%1.19B-37.62%1.28B-40.98%1.29B-37.67%1.51B214.63%1.99B190.35%2.05B276.72%2.19B
Transactional financial assets -27.14%72.76K-33.90%77.54K-29.42%82.8K--91.46K--99.86K-93.33%117.31K-77.63%117.31K----------1.76M
Notes receivable and accounts receivable 22.81%2.23B11.48%2.2B3.16%2.08B19.64%1.89B16.81%1.82B23.29%1.97B43.55%2.01B-26.11%1.58B-31.08%1.56B-32.48%1.6B
-Notes receivable 106.61%60.21M-1.49%54.95M-1.00%49.46M-9.83%53.02M-38.19%29.14M15.58%55.78M6.52%49.96M-15.98%58.8M12.36%47.15M204.41%48.26M
-Accounts receivable 21.45%2.17B11.86%2.14B3.27%2.03B20.78%1.84B18.52%1.79B23.53%1.92B44.83%1.96B-26.45%1.52B-31.90%1.51B-34.07%1.55B
Other receivables (including interest and dividends) -10.58%722.91M-7.87%738.35M-10.41%709.24M-5.41%772.13M-15.43%808.44M-15.52%801.41M-15.10%791.68M-90.93%816.25M-89.36%955.98M-89.48%948.62M
-Other receivable -10.58%722.91M-----10.41%709.24M-----15.43%808.44M-----15.10%791.68M-----89.36%955.98M----
Advance payment -6.45%131.17M-11.94%156.87M-32.48%117.93M-8.37%146.59M-15.17%140.22M-5.25%178.15M22.86%174.66M-38.00%159.99M-32.65%165.3M-24.33%188.03M
Inventories 6.44%2.89B5.96%2.81B-3.89%2.64B-15.18%2.81B-14.33%2.71B-15.74%2.65B-13.90%2.75B-41.12%3.32B-43.28%3.17B-44.24%3.14B
Receivable financing 19.06%26.82M-72.65%12.29M-32.71%16.3M191.18%6.09M1,832.20%22.52M957.21%44.94M-34.23%24.22M-97.40%2.09M-97.73%1.17M-86.70%4.25M
Other current assets 3.77%196.68M6.25%197.59M55.64%187.25M39.64%200.94M38.47%189.54M16.73%185.96M-22.71%120.31M-72.26%143.89M-74.46%136.89M-69.15%159.31M
Total current assets 0.34%6.99B-3.76%6.86B-7.78%6.81B-12.40%7.02B-13.21%6.97B-13.48%7.12B-10.87%7.38B-56.13%8.01B-56.27%8.03B-55.27%8.23B
Non Current assets
Other equity investment -19.73%1.12M-18.67%1.13M-17.19%1.15M37.33%1.37M39.75%1.4M39.12%1.39M39.12%1.39M0.00%1M0.00%1M0.00%1M
Investment real estate 1.15%2.76B1.29%2.78B1.40%2.81B23.36%2.7B23.46%2.73B23.61%2.75B23.42%2.77B-33.57%2.19B-33.44%2.21B-33.61%2.22B
Fixed assets -7.24%3.37B-----7.64%3.45B-----11.07%3.63B-----10.96%3.73B-----19.68%4.09B----
Constru in process -17.79%172.64M-----2.29%210.56M-----20.68%210.01M-----18.26%215.5M-----92.00%264.75M----
Productive biological assets -11.08%679.62K-10.78%700.79K-10.50%721.96K-16.63%743.13K-14.25%764.3K-11.88%785.47K-9.50%806.63K--891.31K--891.31K--891.31K
Intangible assets -8.39%469.98M-8.50%474.16M-7.32%491.02M-9.92%507.82M-9.82%513M-9.75%518.21M-8.61%529.79M-45.40%563.73M-45.46%568.83M-55.70%574.2M
Development expenditure ----------------------------------268.24K-82.83%219.7K
Goodwill 0.00%106.35M0.00%106.35M0.00%106.35M0.00%106.35M0.00%106.35M0.00%106.35M0.00%106.35M188.14%106.35M188.14%106.35M188.14%106.35M
Long deferred expense -21.28%61.48M-20.79%64.44M-23.34%66.47M-20.17%72.47M-19.48%78.09M-21.34%81.35M-21.34%86.71M-0.58%90.77M-0.70%96.99M0.57%103.43M
Deferred tax assets 1.84%100.4M6.75%102.37M4.66%101.48M59.09%98.92M59.63%98.59M56.21%95.9M59.78%96.97M-72.76%62.18M-72.62%61.77M-75.44%61.39M
Usufruct assets -15.51%193.57M-4.34%211.46M-6.51%217.54M6.81%223.53M4.21%229.09M14.55%221.06M24.62%232.69M23.25%209.29M44.04%219.84M16.89%192.97M
Other non current assets 48.38%28.38M62.58%23.43M49.44%21.9M-9.97%23.06M-24.19%19.13M-44.34%14.41M-44.38%14.65M-69.16%25.62M-71.54%25.23M-69.57%25.89M
Total non current assets -4.64%7.26B-4.27%7.35B-4.03%7.47B-0.05%7.55B-0.31%7.62B-0.12%7.68B0.19%7.78B-42.94%7.55B-42.81%7.64B-46.56%7.69B
Total assets -2.26%14.26B-4.02%14.21B-5.86%14.28B-6.41%14.56B-6.92%14.59B-7.03%14.8B-5.52%15.17B-50.59%15.56B-50.60%15.67B-51.45%15.92B
Liabilities
Current liabilities
Short term loan 99.81%23.41M15.18%29.96M2.02%26.14M24.95%33.05M-36.04%11.72M45.24%26.01M68.84%25.62M-98.22%26.45M-98.77%18.32M-99.23%17.91M
Notes payable and accounts payable 19.30%2.52B6.93%2.41B-11.98%2.26B7.73%2.22B7.55%2.12B11.38%2.25B27.22%2.56B-31.35%2.06B-36.31%1.97B-36.24%2.02B
-Notes payable 145.31%89.96M155.06%89.89M68.85%51.33M--48.83M--36.67M--35.24M--30.4M------------
-Accounts payable 17.08%2.43B4.58%2.32B-12.95%2.21B5.36%2.17B5.69%2.08B9.63%2.22B25.71%2.53B-31.35%2.06B-36.31%1.97B-36.24%2.02B
Contract liabilities -23.61%151.91M-26.51%143.82M1.12%159.89M-14.74%195.23M1.12%198.86M2.62%195.72M-18.43%158.12M-46.02%228.98M-57.88%196.66M-56.57%190.71M
Advance receipts -31.21%45.29M-35.94%40.55M4.21%58.65M-7.65%66.47M-7.64%65.85M-21.56%63.31M-15.52%56.28M27.98%71.98M34.64%71.29M12.96%80.7M
Salaries payable -65.32%59.35M-61.04%67.83M-57.80%76.48M-11.83%164.91M-10.39%171.16M-9.49%174.08M-8.34%181.21M-16.35%187.03M-13.15%191M-10.03%192.33M
Taxs payable -57.89%405.33M-58.69%406.88M-42.79%571.3M12.72%963.71M9.79%962.66M-2.50%984.88M-1.78%998.55M89.98%854.93M94.56%876.83M112.32%1.01B
Other payable (including interest and dividends) 0.29%1.37B5.36%1.41B5.54%1.4B12.38%1.38B11.18%1.37B10.66%1.34B7.51%1.33B-70.28%1.23B-70.30%1.23B-70.60%1.21B
-Other payable 0.29%1.37B----5.54%1.4B----11.18%1.37B----7.51%1.33B-----48.02%1.23B----
Non current liabilities due within one year -9.34%36.28M3.41%39.4M4.08%40.71M39.57%40.9M29.98%40.02M19.89%38.1M6.03%39.12M-99.80%29.3M-99.79%30.79M-99.66%31.78M
Other current liabilities -5.31%84.76M-2.25%83.4M-2.77%85.88M-88.32%89.3M-44.52%89.51M-47.82%85.32M-47.03%88.32M-73.81%764.37M-94.47%161.35M-94.39%163.5M
Total current liabilities -6.39%4.7B-10.23%4.63B-13.99%4.68B-5.48%5.15B5.90%5.02B4.87%5.16B10.01%5.44B-79.92%5.45B-82.61%4.74B-78.77%4.92B
Current liabilities
Long term account payable -4.27%805.12M-----5.64%805.83M----195.44%841.01M----191.43%853.96M------284.66M----
Estimate liabilities -15.14%823.83M-15.04%832.44M-12.76%855.54M--894.27M--970.78M--979.81M--980.63M------------
Deferred tax liabilities -18.62%46.43M-7.88%50.66M-6.93%51.68M--55.69M--57.06M--54.99M--55.53M------------
Long term deferred income -5.34%603.42M-5.43%610.9M-5.40%618.68M-5.66%629.6M-5.57%637.46M-5.50%645.98M-5.63%653.98M-32.20%667.34M-31.98%675.06M-33.37%683.56M
Lease liabilities -11.63%176.46M-1.59%186.62M-5.51%188.16M3.64%195.86M1.77%199.68M12.78%189.63M29.96%199.13M11.91%188.98M27.94%196.2M1.27%168.15M
Total non current liabilities -9.27%2.46B-8.36%2.49B-8.14%2.52B148.30%2.58B134.10%2.71B137.01%2.71B140.80%2.74B-93.41%1.04B-92.67%1.16B-94.45%1.14B
Total liabilities -7.40%7.16B-9.59%7.12B-12.03%7.2B19.16%7.73B31.01%7.73B29.82%7.87B34.49%8.18B-84.88%6.49B-86.29%5.9B-86.15%6.06B
Shareholders equity
Paid-in capital 0.00%13.86B0.00%13.86B0.00%13.86B0.00%13.86B0.00%13.86B0.00%13.86B0.00%13.86B178.73%13.86B178.73%13.86B178.73%13.86B
Capital reserve funds 0.00%18.78B0.00%18.78B0.00%18.78B0.00%18.78B0.00%18.78B0.00%18.78B0.00%18.78B62.26%18.78B62.26%18.78B62.26%18.78B
Surplus reserve funds 0.00%1.53B0.00%1.53B0.00%1.53B0.00%1.53B0.00%1.53B0.00%1.53B0.00%1.53B0.00%1.53B0.00%1.53B0.00%1.53B
Retained profit 0.93%-25.89B0.62%-25.89B0.39%-25.9B-8.06%-26.15B-11.13%-26.13B-11.21%-26.05B-11.53%-26B24.93%-24.2B26.85%-23.51B26.35%-23.43B
Less:Treasury stock 0.45%1.22B0.24%1.23B0.26%1.23B29.81%1.22B30.67%1.22B31.01%1.22B30.99%1.22B173.85%940.95M171.48%932.82M171.48%932.82M
Other composite income -274.61%-251.97K-190.09%-121.82K-173.69%-100.05K146.61%122.37K154.89%144.31K150.94%135.23K151.15%135.77K92.67%-262.52K92.65%-262.93K92.62%-265.45K
Specific reserves 16.33%1.37M-6.80%1.21M-1.35%1.28M-65.76%1.15M-65.02%1.18M-61.51%1.3M-61.51%1.3M--3.36M--3.37M--3.37M
Shareholders equity without minority interests 3.49%7.06B2.28%7.05B1.43%7.05B-24.71%6.8B-29.86%6.83B-29.72%6.9B-30.00%6.95B178.26%9.03B185.01%9.73B188.33%9.82B
Minority interests 9.58%35.75M5.72%34.33M-7.16%32.89M-20.30%33.3M-22.42%32.63M-22.27%32.48M-15.48%35.43M-68.94%41.79M-68.60%42.05M-66.56%41.78M
Total shareholder equity 3.52%7.1B2.29%7.09B1.38%7.08B-24.69%6.83B-29.83%6.86B-29.69%6.93B-29.94%6.98B179.55%9.07B186.39%9.77B189.71%9.86B
Total liabilityies and equity -2.26%14.26B-4.02%14.21B-5.86%14.28B-6.41%14.56B-6.92%14.59B-7.03%14.8B-5.52%15.17B-50.59%15.56B-50.60%15.67B-51.45%15.92B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Tianzhu International Accounting Firm (Special General Partnership)------Tianzhu International Accounting Firm (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data